首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 187 毫秒
1.
松弛素     
<正> 松弛素(Relaxin简称RLX)系哺乳类动物卵巢黄体分泌的一种多肽激素。在体内具有松弛耻骨韧带,抑制子宫收缩、软化子宫颈,刺激乳腺发育,影响乳汁分泌等多种生理功能。Hisaw(1926年)首先进行了将孕兔的血清注射于未孕的豚鼠皮下使豚鼠耻骨韧带产生松弛的实验。Fevlod(1930 )等证明了母猪黄体的水提取物能使注射了雌激素的去卵巢豚鼠的耻骨韧带松弛、并将具有这种生物活性的物质命名为“RLX”。随着蛋白质分离技术发展和RLX生物活性鉴定方法的建立促进了RLX的研究。近年来,在RLX的生物化学、生  相似文献   

2.
3.
甘草素与异甘草素的合成   总被引:3,自引:0,他引:3  
杨立  沈凤嘉 《药学学报》1994,29(11):877-880
甘草素与异甘草素的合成杨立,沈凤嘉(兰州大学化学系,兰州730000)甘草(Glycyrrhizauralensisfisch.)为我国一项宝贵的中药资源,历来受到人们重视。甘草素(liquiritigenin)和异甘草素(isoliquiritig...  相似文献   

4.
郑巧燕 《海峡药学》2013,(8):108-110
目的综述水蛭素、重组水蛭素的药理作用与临床应用研究进展,为其临床应用提供参考。方法依据近年采国内外文献,进行分析、归纳和总结。结果与结论水蛭素、重组水蛭素是迄今发现的活性最强的特异性凝血酶抑制剂,通过与凝血酶特异性结合而产生强有力地抑制血液凝固的作用,在心、脑血管系统疾病等方面的抗凝、抗血栓的应用广泛,药物开发前景广阔。  相似文献   

5.
6.
多杀菌素     
Natroba(商品名),是由Parapro Pharms公司研发的一种外用制剂,有效成分为spinosad,中文名称为多杀菌素或刺糖菌素。美国食品和药品管理局(FDA)于2011年1月18日批准0.9%spinosad(Natroba)的外用混悬液用于4岁及以上患者的头虱感染治疗[1]。  相似文献   

7.
本品系从牛眼内容物(水晶体、玻璃体、房水、部分视网膜和色素膜)中提取的一种生物制品,其成份由多种氨基酸、多肽、核苷酸、其他有机酸及微量钙镁等多种金属离子所组  相似文献   

8.
当归素片     
当归素片(又名:阿魏酸钠片,Tab.Natrii Ferulatis.)系活血化瘀中药当归及川的有效成分。为一人工合成的治疗偏头痛等症的新药。[作用与用途]具有抗血小板凝聚、抑制5-  相似文献   

9.
伊洛前列素     
陈应萍 《中国新药杂志》2006,15(14):1217-1218
[通用名称] iloprost inhalation solution,伊洛前列素吸入溶液 [商品名]Ventavis [性状]本品为溶液剂,内容物为无色或黄色的澄清液体。 [化学名称]5-{(E)-(1S,5S,6R,7R)-7-羟基-6-[(E)-(3S,4RS)-3-羟基-4-甲基-1-辛烯-6-炔基]-双环[3.3.0]辛-3-亚基}-戊酸  相似文献   

10.
乳酸菌素片     
乳酸菌素片是黑龙江省阎家岗制药厂在总结了乳酶生不足的基础上,选用长期服用不引起亚急性心内膜炎的乳酸杆菌的菌种,并用天然鲜牛奶为培养基,经接种发酵后的发酵液和乳酸菌的菌体及其代谢产物的混合干燥物。是一种可参与人体内代谢的、具有生理活性的、乳酸菌的代谢  相似文献   

11.
AIM: To explore the inhibitory effect of antisense oligonucleotide (ODN) to mitogen activated protein kinase(MAPK) on cardiomyocyte hypertrophy induced by angiotensin Ⅱ (Ang Ⅱ). METHODS: A 17-mer phosphorothioate-protected antisense ODN directed against the initiation of translation sites of the p42 and p44 MAPK isoforms byliposomal transfection was applied to inhibit the translation of p44/p42 MAPK mRNA. The sense and random ODNs to p44/p42MAPK were used as sequence controls. Neonatal cardiac myocytes were exposed to Ang Ⅱ (10nmol/L) for 5 min and then harvested in lysis buffer for the measurement of the activity and the phosphorylated protein content of p44/p42MAPK that were tested by P-81 phosphocellulose filter paper method and Western blotting, respectively. The rate of protein synthesis by [^3H]leucine incorporation and the diameter of cell were measured after exposure to Ang Ⅱ for 24 h and 72 h, respectively. RESULTS: In cardiac myocyte Ang Ⅱ increased p44/p42MAPK activity and phosphorylated protein content by 140 % and 699 %, and also increased [^3H]leucine incorporation and cell diameter by 40 % and 27 %. c-fos and c-myc mRNAs were induced significantly after exposure to Ang Ⅱ. Antisense ODN to p44/p42MAPK (0.2 μmol/L) reduced Ang Ⅱ-induced MAPK activity by 30 %,and phophorylated MAPK protein expression by 59 % in cardiac myocyte, and inhibited c-fos and c-myc mRNA expression induced by Ang Ⅱ by 44 % and 43 %, respectively. The diameter and the rate of protein synthesis of cardiac myocyte induced by Ang Ⅱ were decreased by 16 % and 22 % after pretreatment with antisense ODN to p44/p42MAPK. CONCLUSION: Antisense ODN to p44/p42 MAPK inhibited the increase of rate of protein synthesis,and the augmentation of cell diameter and expression of c-fos and c-myc mRNA induced by Ang Ⅱ in culturedcardiac myocytes, p44/p42 MAPK played a critical role in the hypertrophic response induced by Ang Ⅱ in cultured neonatal rat cardiac myocytes.  相似文献   

12.
目的:探讨丝裂素活化的蛋白激酶(NAPK)反义寡核苷(ODN)对表皮生长因子(EGF)诱导的培养大鼠血管平滑肌细胞增生的抑制作用。方法:用脂质体将P42-和P44-MAPK ODN0.2μmolˉL^-1转染入大鼠血管平滑肌细胞,设正义及随机ODN为对照,用Western Blot法结合P-81滤纸法以髓磷脂碱性蛋白为底物测定MAPK活性。[^3H]胸腺嘧啶核苷酸掺入测定平滑肌细胞DNA合成。结果  相似文献   

13.
AIM: To analyze the target selective and sequence-specific inhibitory effect of mitogen-activated protein kinase (MAPK) phosphorothioate antisense oligodeoxynucleotides (ODN) on p42/p44, p38 MAPK, c-jun NH2-terminal protein kinases (JNK) protein expression, and DNA synthesis in vascular smooth muscle cell (VSMC). METHODS: Using a phosphorothioate-protected 17-mer antisense MAPK ODN directed against the initiation of translation sites of the p42/p44 MAPK isoforms by liposomal transfection to deplete cultured rat, rabbit, and fetal calf VSMC MAP kinases. The 17-mer sense and random sequence MAPK ODN were used as controls. After liposomal transfection, cells were exposed to 20% serum for 24 h, and then harvested in lysis buffer. P42/p44, p38 MAPK, and p46/p58 JNK protein expression were measured by Western blot. DNA synthesis was measured by [3H]thymidine incorporation. RESULTS: Treatment with MAPK antisense ODN (0.1-0.8 mumol.L-1) for 48 h reduced phosphored p42/p44 MAPK protein expression but without effect on p38 MAPK and JNK expression, and inhibited cultured rat, rabbit, and fetal calf VSMC [3H]thymidine incorporation stimulated by 20% serum in a concentration-dependent manner. CONCLUSION: The MAPK antisense ODN target-selectively and sequence-specifically reduces the p42/p44 MAPK protein expression and concentration-dependently inhibits proliferation of rat, rabbit and fetal calf VSMC.  相似文献   

14.
AIM: To study the effect of antisense basic fibroblast growth factor (bFGF) oligonucleotides (ODN) transfection on the growth of cultured aortic smooth muscle cells (SMC) in spontaneously hypertensive rats (SHR). METHODS: Using cationic liposome-mediated method, antisense bFGF ODN were introduced into SMC, bFGF gene expression was detected by Northern blotting, cell hyperplasia was evaluated by [3H] thymidine incorporation and cell counting. RESULTS: Transfection of antisense bFGF ODN (5 mumol.L-1) almost completely inhibited enhanced bFGF mRNA expression and inhibited cell proliferation induced by angiotensin II (Ang 1 mumol.L-1). In basal state and Ang-stimulated state, [3H]thymidine incorporation was inhibited by 26.5% (P < 0.01) and 42.0% (P < 0.01) and cell number was inhibited by 17.3% (P < 0.01) and by 22.2% (P < 0.01), respectively. CONCLUSION: The transfection of antisense bFGF ODN into cultured SMC effectively suppressed bFGF mRNA expression and inhibited the SMC proliferation induced by Ang.  相似文献   

15.
AIM: To investigate the role of Ca(2+)-calmodulin dependent protein kinase (CCDPK) on basic fibroblast growth factor (bFGF)-induced vascular smooth muscle cell (VSMC) proliferation and the inhibitory effect of antisense CCDPK oligonucleotides (ODN). METHODS: Before being exposed to bFGF, cultured rat VSMC CCDPK activity was inhibited by pretreatment with either a phosphorothioate-protected 17-mer antisense CCDPK ODN-directed against the initiation of translation sites of the p42 and p44 CCDPK isoform or with CCDPK kinase inhibitor PD98059. All ODN were introduced into cells by liposomal transfection. DNA synthesis was measured by [3H]thymidine incorporation. P44- and p42-CCDPK protein expression and phosphorylation were measured by Western blot. RESULTS: PD98059 inhibited bFGF-induced phosphorylation of CCDPK and DNA synthesis. Antisense CCDPK ODN 0.2-0.8 mumol.L-1 reduced both p44- and p42-CCDPK expression and phosphorylation of CCDPK in a concentration-dependent manner and DNA synthesis induced by bFGF. Lipofectin alone or sense and random CCDPK ODN did not affect p44- and p42-CCDPK protein expression or bFGF-induced phosphorylation of CCDPK or DNA synthesis. CONCLUSION: bFGF-stimulated rat VSMC proliferation is mediated by CCDPK. The antisense CCDPK ODN can inhibit bFGF-induced VSMC proliferation through down-regulating p44- and p42-CCDPK level.  相似文献   

16.
AIM: To investigate whether the effect of angiotensin (Ang) II or epidermal growth factor (EGF) on cardiac fibroblast proliferation involved in activation of extracellular signal-regulated kinase (ERK) 1/2 or Ca(2+)-calmodulin dependent protein kinase(CCDPK) mediated by protein kinase C (PKC)-zeta. METHODS: Relative activity of CCDPK was measured by Western blotting. DNA synthesis was assayed by [3H]thymidine incorporation. RESULTS: PDBU caused no decrease in Ang II- and 10% FCS-stimulated CCDPK activity and DNA synthesis. In contrary, 65% or 75% EGF- or tetradecanoylphorbol acetate (TDPA, formally called PMA)--stimulated CCDPK activity and 38% or 42% [3H]thymidine incorporation treated by PDBU were inhibited, respectively. Meanwhile 70% and 72% CCDPK activities induced by Ang II and EGF were inhibited by PD 98059, respectively. CONCLUSION: PKC-zeta mediated Ang II-induced activation of CCDPK and cardiac fibroblast proliferation.  相似文献   

17.
目的:探讨Ca^2 -钙调蛋白依赖性蛋白激酶(丝裂素活化的蛋白激酶)(CCDPK)在生长因子诱导体外培养大鼠血管平滑肌细胞增殖中的作用及反义CCDPK寡脱氧核苷酸(ODN)对球囊损伤后大白鼠血管内膜增生的抑制作用。方法:利用脂质体转染17-mer CCDPK反义ODN进入培养的血管平滑肌细胞以抑制CCDPK活性,设正义及随机ODN作对照。用蛋白质印迹法测定CCDPK表达。[^3H]胸腺嘧啶核苷酸掺入测定平滑肌细胞DNA合成。用2F球囊导管造成大白鼠颈动脉再狭窄模型,利用多聚胶F127-ODN系统由血管外膜部位给药。于损伤后2周取样,固定及HE染色观察内膜增生情况。FITC标记的ODN观察体内外给药方法的分布及吸收情况。结果:CCDPK反义ODN能明显抑制PDGF及ET诱导的CCDPK蛋白表达及[^3H]胸腺嘧啶核苷酸掺入。在大鼠颈动脉再狭窄模型,能明显抑制血管内膜增生。结论:CCDPK介导了PDGF及ET诱导的血管平滑肌细胞增殖。针对p42-和p44-CCDPK起始部位设计的17-mer反义ODN能有效抑制生长因子诱导的血管平滑肌细胞的增殖及球囊损伤大鼠血管内膜增生。  相似文献   

18.
19.
AIM: To study whether endogenous kinins are negative modulators in the growth of cardiomyocytes and their possible cellular and molecular mechanisms. METHODS: Cultured neonatal rat cardiomyocytes were used. Intracellular RNA and protein synthesis were measured by [3H]uridine incorporation and [3H]leucine incorporation, respectively. The expression level of proto-oncogene c-myc, c-fos mRNA was observed by Northern blotting. RESULTS: Exposure of cardiomyocytes to captopril (Cap, 100 mumol.L-1) for 48 h inhibited the rates of [3H]Urd and [3H]Leu incorporations by 25% and 26%, respectively, and for 2 h inhibited c-myc, c-fos mRNA expression by 75% and 55%, respectively. Treatment of angiotensin II (Ang II, 1 mumol.L-1) for 48 h significantly increased the rates of [3H]Urd and [3H]Leu incorporations and for 1 h induced c-myc, c-fos mRNA overexpression, which were reduced by pretreatment with Cap (100 mumol.L-1). Icatibant acetate (Hoe 140, a specific antagonist of bradykinin B2 receptor) 0.1-10 mumol.L-1 blocked the effects of Cap in a concentration-dependent manner. CONCLUSION: Endogenous kinins exhibited a negative modulatory effect on growth of cardiomyoctes via BK B2 receptor.  相似文献   

20.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号